Wang Y, Liu Q, Jiang Y, Mao L, Zoubaa M, Wang J
CNS Neurosci Ther. 2025; 31(3):e70302.
PMID: 40079428
PMC: 11904945.
DOI: 10.1111/cns.70302.
Guerini A, Mataj E, Borghetti P, Triggiani L, Pegurri L, Nici S
Adv Radiat Oncol. 2025; 10(3):101696.
PMID: 39911722
PMC: 11795776.
DOI: 10.1016/j.adro.2024.101696.
Wang X, Li L, Wang Y
J Pain Res. 2025; 18:315-326.
PMID: 39867539
PMC: 11760761.
DOI: 10.2147/JPR.S498466.
Li K, Guo B, Gu J, Ta N, Gu J, Yu H
Mater Today Bio. 2025; 30:101375.
PMID: 39759851
PMC: 11699619.
DOI: 10.1016/j.mtbio.2024.101375.
Wang L, Xu X, Su S, Li B, Zhang K, Yu X
Sci Rep. 2024; 14(1):31851.
PMID: 39738518
PMC: 11685590.
DOI: 10.1038/s41598-024-83027-w.
Meta-analysis of the effect of sophora flavescens on tumor metastasis-induced bone neuropathic pain.
Chang C, Sun D, Zhang Z, He L, Wang Q, Shen Y
Front Pharmacol. 2024; 15:1474982.
PMID: 39629083
PMC: 11611551.
DOI: 10.3389/fphar.2024.1474982.
Liu-Shen-Wan inhibits PI3K/Akt and TRPV1 signaling alleviating bone cancer pain in rats.
Zhang H, Jiang J, Chen X, Zhu F, Fu F, Chen A
Cancer Biol Ther. 2024; 25(1):2432098.
PMID: 39587385
PMC: 11601056.
DOI: 10.1080/15384047.2024.2432098.
Chemokine CXCL13-CXCR5 signaling in neuroinflammation and pathogenesis of chronic pain and neurological diseases.
Zheng K, Chen M, Xu X, Li P, Yin C, Wang J
Cell Mol Biol Lett. 2024; 29(1):134.
PMID: 39472796
PMC: 11523778.
DOI: 10.1186/s11658-024-00653-y.
Histone modifications and Sp1 promote GPR160 expression in bone cancer pain within rodent models.
Xu C, Wang Y, Ni C, Xu M, Yin C, He Q
EMBO Rep. 2024; 25(12):5429-5455.
PMID: 39448865
PMC: 11624276.
DOI: 10.1038/s44319-024-00292-6.
Chronic Pain and Bone-Related Pathologies: A Narrative Review.
Pickering M, Delay M, Morel V
J Pain Res. 2024; 17:2937-2947.
PMID: 39253740
PMC: 11382656.
DOI: 10.2147/JPR.S469229.
Involvement of HDAC2-mediated kcnq2/kcnq3 genes transcription repression activated by EREG/EGFR-ERK-Runx1 signaling in bone cancer pain.
Zhang Z, Tian Y, Li S, Jing H, Cai J, Li M
Cell Commun Signal. 2024; 22(1):416.
PMID: 39192337
PMC: 11350972.
DOI: 10.1186/s12964-024-01797-2.
Metformin relieves bone cancer pain by reducing TGFβRI-TRPV1 signaling in rats.
Zhou F, Qian H, Wang K, Gu Y, Liu P, Zhang L
Heliyon. 2024; 10(15):e34991.
PMID: 39157315
PMC: 11328085.
DOI: 10.1016/j.heliyon.2024.e34991.
Content validation of the National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lymphoma Symptom Index-18 (NFLymSI-18) in indolent B-cell non-Hodgkin's lymphoma.
Hurt C, Kaiser K, Shaunfield S, Webster K, Keating K, Boyken L
J Patient Rep Outcomes. 2024; 8(1):68.
PMID: 38980533
PMC: 11233475.
DOI: 10.1186/s41687-024-00752-6.
Unveiling the therapeutic promise: exploring Lysophosphatidic Acid (LPA) signaling in malignant bone tumors for novel cancer treatments.
Qi Y, Wang Y, Yuan J, Xu Y, Pan H
Lipids Health Dis. 2024; 23(1):204.
PMID: 38943207
PMC: 11212261.
DOI: 10.1186/s12944-024-02196-9.
Molecular targets in bone cancer pain: a systematic review of inflammatory cytokines.
Ruivo J, Tavares I, Pozza D
J Mol Med (Berl). 2024; 102(9):1063-1088.
PMID: 38940936
PMC: 11358194.
DOI: 10.1007/s00109-024-02464-2.
Osteosarcoma-Induced Pain Is Mediated by Glial Cell Activation in the Spinal Dorsal Horn, but Not Capsaicin-Sensitive Nociceptive Neurons: A Complex Functional and Morphological Characterization in Mice.
Bencze N, Scheich B, Szoke E, Wilhelm I, Kormondi S, Botz B
Cancers (Basel). 2024; 16(10).
PMID: 38791867
PMC: 11120600.
DOI: 10.3390/cancers16101788.
MOTS-c is an effective target for treating cancer-induced bone pain through the induction of AMPK-mediated mitochondrial biogenesis.
Yang L, Li M, Liu Y, Bai Y, Yin T, Chen Y
Acta Biochim Biophys Sin (Shanghai). 2024; 56(9):1323-1339.
PMID: 38716540
PMC: 11532206.
DOI: 10.3724/abbs.2024048.
Analysis of Ionomic Profiles of Spinal Cords in a Rat Model with Bone Cancer Pain.
Huang J, Chen J, Ma L, Zhu X, Wan L, Li X
J Pain Res. 2024; 17:1531-1545.
PMID: 38682106
PMC: 11055530.
DOI: 10.2147/JPR.S447282.
Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation.
Zeng F, Wade A, Harbert K, Patel S, Holley J, Dehghanpuor C
Sci Rep. 2024; 14(1):5782.
PMID: 38461339
PMC: 10924854.
DOI: 10.1038/s41598-024-56220-0.
Esketamine inhibits the c-Jun N-terminal kinase pathway in the spinal dorsal horn to relieve bone cancer pain in rats.
Duan C, Zhu Y, Zhang Z, Wu T, Shen M, Xu J
Mol Pain. 2024; 20:17448069241239231.
PMID: 38417838
PMC: 10938627.
DOI: 10.1177/17448069241239231.